Procept Biorobotics Corporation's revenue worldwide 2021-2023, by market

The American medical technology and robotics company, Procept Biorobotics Corporation, reported over 136 million U.S. dollars in revenue in 2023. Most of its revenue was generated by its hand-pieces and other consumables market in 2023, in contrast with the previous years, when the largest revenue share was brought by the company's system sales and rentals market.

Research and development budget growing fast

Procept Biorobotics nearly doubled its R&D budget between 2022 and 2023, growing it from just under 30 thousand U.S. dollars to nearly 50 thousand. This is understandable in the current fast-moving AI and robotic development atmosphere. It has helped them launch themselves into the company of the largest robotics companies.

Medical robots growing considerably

In 2024, the global medical service robotics market generated a revenue of 11.2 billion U.S. dollars. The market was forecast to continue to grow and reach almost 21 billion U.S. dollars by 2028. This market is unlikely to see downshifts as aging populations across the world will require more assistance and care in the coming decades. Procept is therefore well-placed to capitalize on the market growth and increased demand for its products.